SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive analyst upgrade that highlights the company's progress in regulatory pathways and validates the therapeutic potential of its lead candidate, Sonelokimab. Investors are actively discussing the stock's significant long-term growth prospects, the potential for a strategic buyout, and the upcoming clinical data readouts that are expected to solidify the drug's position as a best-in-class treatment.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors closely monitor the development of Project Matador and anticipate a potential tenant announcement, following reports of a substantial equipment financing facility and strategic partnerships. The community remains actively divided, with many debating the company's timeline for operational capacity and power grid integration, while others highlight the massive short interest and potential for a significant upside breakout once a definitive data center tenant is secured.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened trading activity as the company's recent operational updates and offtake agreements drive significant investor interest, leading to strong buying momentum in the stock. The community is actively debating the stock's potential for a breakout, with many discussing the impact of lithium supply-demand dynamics and monitoring insider buying as a key indicator of confidence in future growth.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Gold and Silver Corporation

Americas Gold and Silver is trending as investors monitor the company's recent acquisition of the Crescent Silver Mine and its strategic positioning in the domestic antimony market. Market participants are actively discussing the stock's high institutional ownership and potential for rapid growth as the company aims to quadruple silver production while benefiting from record-high precious metal prices.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is trending following the TETON-1 study's success in meeting its primary efficacy endpoint for treating idiopathic pulmonary fibrosis, driving investor optimism regarding the company's pipeline expansion. The community is actively discussing the drug's potential market impact, the competitive landscape involving inhaled treprostinil treatments, and broader implications for the company's valuation as it maintains its strong commercial presence.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing intense scrutiny following the release of elegrobart REVEAL-1 phase 3 data, which triggered a significant pre-market stock decline despite meeting primary endpoints. Investors are actively debating the drug's competitive positioning against current standard-of-care treatments, with community sentiment divided between those viewing the pullback as a buying opportunity and skeptics questioning its long-term viability without head-to-head trial data.

Roma Green Finance Ltd. is a holding company, which engages in the provision of environmental, social and governance, sustainability, and climate change related advisory services through its subsidiaries. Its services include corporate and risk advisory, sustainability strategy services, climate risk advisory, ESG reporting services, and sustainable finance. The company was founded in 2018 and is headquartered in Hong Kong.

Roma Green Finance Ltd - Ordinary Shares - Class A

Roma Green Finance Ltd

Roma Green Finance is trending following the board's authorization of a 100 million dollar share repurchase program, sparking intense community debate over its potential to boost shareholder value versus concerns about the company's long-term financial health. Traders are closely monitoring the stock's significant volatility and trading volume, with many actively discussing whether the buyback will support a sustained upward trend or if the stock remains vulnerable to typical small-cap pump-and-dump dynamics.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trading near multi-year lows, fueling intense debate among retail traders regarding whether the stock is an oversold value opportunity ahead of earnings or a value trap facing structural headwinds in China. While some investors are pointing to insider buying and historical support levels as a signal to accumulate, others remain skeptical, citing ongoing inventory issues, declining margins, and stiff competition from newer athletic brands.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific (BSX) is trending following positive data from the Champion-AF clinical trial, which confirmed the safety and efficacy of the Watchman FLX device compared to standard anticoagulants. Community discourse remains highly active, balancing excitement over the company's clinical innovation with skepticism driven by ongoing litigation, recent analyst price target adjustments, and the broader macro-driven rotation within the medtech sector.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is capturing market attention as traders highlight its potential for a short squeeze and long-term utility in the decentralized internet space, with many comparing its setup to previous breakout tokens. The community is actively discussing bullish chart formations, accumulation opportunities, and various ecosystem developments, fueling speculation about significant upward price movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nippon Steel completes acquisition of U.S. Steel in historic deal

Investing.com - Nippon Steel Corporation (TSE: 5401) has finalized its acquisition of United States Steel (NYSE:X), the companies announced Wednesday. The deal, valued at approximately $14.9 billion, creates what the companies describe as a "world-leading steelmaker."

Jefferies downgrades Nippon Steel on U.S. Steel deal risks

Investing.com -- Jefferies has lowered its rating on Nippon Steel Corp (TYO:5401) stock to Underperform, citing multiple financial and operational risks tied to its planned acquisition of United States Steel (NYSE:X).

Trump Approves Nippon's $14.9B Deal For US Steel Deal — But Retail Sentiment Stays BearishU.S President Donald Trump approved Nippon Steel’s bid for U.S. Steel (X) worth $14.9 billion on Friday.Although U.S. Steel shares ended Friday down 2.8%, the news triggered a 5.1% rebound in aftermarket trading, pushing the stock up to $54.85.The companies have also signed a National Security Agreement (NSA) with the U.S. Government, committing to around $11 billion in new investments by 2028. The NSA includes an initial investment in a greenfield project expected to be completed after 2028.The agreement also outlines commitments related to governance, domestic production, and trade, including the issuance of a Golden Share to the U.S. Government, which grants it special voting rights in certain situations. However, neither company disclosed further details regarding the Golden Share.Last month, Republican Senator David McCormick of Pennsylvania indicated that the U.S. would likely hold veto powers over key decisions at the 124-year-old firm.White House trade adviser Peter Navarro echoed the sentiment, “U.S. Steel owns the company. Nippon Steel is going to have some involvement but no control.”The deal will mark the conclusion of a turbulent 18-month period for Nippon Steel in its bid to acquire the American company, a process marked by multiple challenges, including union resistance and two national security reviews.Alongside President Trump’s Executive Order, the companies have also completed the U.S. Department of Justice review process.Retail sentiment on Stocktwits remained ‘bearish’ with users apprehensive about the deal's conclusion.<stembedurl>https://stocktwits.com/Slingshot849/message/617928576</stembedurl><stembedurl>https://stocktwits.com/Slingshot849/message/617918982</stembedurl>One user said that the stock is overpriced and could fall to $30 levels.<stembedurl>https://stocktwits.com/Slingshot849/message/617914605</stembedurl>Year-to-date, the stock has gained around 53% as of Friday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.

United States President Donald Trump departs at the White House to U.S. Steel's Irvin Works in West Mifflin, Pennsylvania in Washington D.C May 30, 2025. (Photo by Celal Gunes/Anadolu via Getty Images)

Trump Approves Nippon's $14.9B Deal For US Steel Deal — But Retail Sentiment Stays Bearish

The companies have also signed a National Security Agreement with the U.S. Government, committing to around $11 billion in new investments by 2028

Equity

U.S. Steel (X) continued to garner retail attention on Tuesday after reports and the comments from a lawmaker indicated that the U.S. would likely hold veto powers over key decisions at the 124-year-old firm.The stock rose 2% during the regular trading session, after touching a 14-year high on Friday when Trump indicated his approval for the company’s merger with Japan’s Nippon Steel."It'll be a U.S. CEO, a U.S. majority board, and then there will be a golden share, which will essentially require U.S. government approval of a number of the board members, and that will allow the United States to ensure production levels aren’t cut and things like that," said Republican Senator David McCormick of Pennsylvania in a CNBC interview.The first-time senator’s comments followed a report by Nikkei, which mentioned that Nippon and the U.S. were exploring the issuance of a so-called golden share, which allows the holders of such shares to outvote others in some specific cases.However, McCormick did not elaborate on the administration’s final decision on the original $14.9 billion acquisition deal.Bloomberg <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-05-27/us-set-to-receive-golden-share-as-part-of-us-steel-nippon-deal">reported</a>, citing people familiar with the matter, that the agreement tabled in front of the Committee on Foreign Investment in the U.S. (CFIUS) and the Trump administration included the original $55 per share offer alongside additional investments.It was also not clear whether the powers granted to the U.S. would include an equity stake or just mitigation powers, the report added.The deal, announced in December 2023, has faced numerous roadblocks, with both Joe Biden and Trump voicing their opposition to the agreement during an intense campaign in the crucial swing state of Pennsylvania.Biden even blocked the deal during the last days of his administration after the first CFIUS review on national security grounds. Trump ordered a fresh review following requests by both the companies and even the Japanese Government.On Friday, Trump announced a partnership that would bring $14 billion to the U.S. economy and keep the company U.S.-owned without divulging details.Retail sentiment on Stocktwits was ‘extremely bullish’ (80/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:882/106;" src="https://news.stocktwits-cdn.com/X_May_28_JPG_bcbe604d26.webp" alt="X’s Sentiment Meter and Message Volume as of 03:10 a.m. ET on May 28, 2025 | Source: Stocktwits" width="882" height="106"><figcaption>X’s Sentiment Meter and Message Volume as of 03:10 a.m. ET on May 28, 2025 | Source: Stocktwits</figcaption></figure>“Let's wrap this deal before anyone changes their mind. I expect a quick close,” one user said.<stembedurl>https://stocktwits.com/drbrain00/message/615989900</stembedurl><a href="https://stocktwits.com/symbol/X">U.S. Steel stock</a> has gained 55% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/southwest-airlines-could-net-430-m-from-new-baggage-fees-says-analyst-but-retail-traders-stay-cautious/ch0oeUkRbrt">Southwest Airlines Could Net $430M From New Baggage Fees, Says Analyst — But Retail Traders Stay Cautious</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A general view of the exterior of the U.S. Steel Tower, headquarters of USX Steel, on March 20, 2024, in Pittsburgh, Pennsylvania. (Photo by Jeff Swensen/Getty Images)

America Likely To Get Veto Powers After US Steel’s Merger With Nippon, Retail Cheers

Nippon and the U.S. were exploring the issuance of a so-called golden share, which allows the holders of such shares to outvote others in some specific cases.

Asia stocks mixed amid Trump tariff uncertainty; Japan extends gains

Investing.com-- Most Asian markets were a mixed bag on Monday after U.S. President Donald Trump threatened and then backtracked on increased European trade tariffs over the weekend, while Japanese shares extended a run of recent gains.

Nippon Steel shares surge after Trump supports US Steel deal

Investing.com-- Shares of Japan’s Nippon Steel Corp (TYO:5401) jumped on Monday after U.S. President Donald Trump expressed support for the company’s $14.9 billion bid to acquire U.S. Steel (NYSE:X).

US panel divided over Nippon Steel’s proposed takeover of US Steel – Reuters

Investing.com-- A U.S. national security panel delivered a divided recommendation to President Donald Trump on Nippon Steel Corp’s (TYO:5401) proposed takeover of U.S. Steel Corp (NYSE:X), though most members believe any risks can be mitigated, Reuters reported on Thursday, citing a White House official.

Nippon Steel shares soar as Trump orders new review of US Steel takeover

Investing.com-- Nippon Steel shares rose sharply on Tuesday after U.S. President Donald Trump ordered a new review of the company’s takeover of U.S. Steel, which was blocked by the Biden administration. 

Shares of United States Steel Corp. (X) surged by more than 7.5% in Thursday’s after-market hours&nbsp;as Japan’s Nippon Steel Corp. (NPSCY)&nbsp;reportedly considers boosting its investment to&nbsp;rebuild its American rival’s facilities.&nbsp;Nippon Steel and U.S. Steel are in talks with the Trump administration as they seek the government’s approval for the $14.1 billion takeover bid, according <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.semafor.com/article/03/27/2025/us-steel-and-nippon-are-in-talks-to-revive-merger-that-trump-had-threaten-to-block">to</a> a Semafor report, citing people familiar with the matter.Nippon has tried to sweeten its takeover bid by significantly increasing its investment pledge to $7 billion from $2.7 billion. This investment will be made in rebuilding U.S. Steel’s aging manufacturing facilities.This comes at a time when Nippon’s acquisition bid for U.S. Steel is stuck in limbo after the Biden administration blocked it on national security grounds.On his part, President Donald Trump has publicly voiced his opposition to Nippon’s acquisition offer. In a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/113586503722263487">post</a> on his social media platform Truth Social, Trump said, “I am totally against the once great and powerful U.S. Steel being bought by a foreign company, in this case Nippon Steel of Japan.”However, another <a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-surges-on-reports-that-trump-is-considering-allowing-acquisition-by-nippon/chPzHvXRt7">report</a> in February stated that Trump might be amiable to the deal, but it was not definite at the time.While the Nippon Steel deal is in limbo, Cleveland-Cliffs Inc. (CLF) and Nucor Corp. (NUE) were&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-steady-ahead-of-q4-earnings/chbAYwvRqI">reportedly</a> interested in a joint bid to acquire U.S. Steel.Amid this, U.S. Steel’s first-quarter <a href="https://stocktwits.com/news-articles/markets/equity/us-steel-stock-declines-aftermarket-on-weak-guidance/ch788SVRbPs">guidance</a> came in below Wall Street expectations. The company expects a loss per share between $0.49 and $0.53, while the consensus estimate was for a loss of $0.33 per share.Retail sentiment on Stocktwits around U.S. Steel remained in the ‘extremely bullish’ (91/100) territory, showing exuberance among investors.<figure class="image"><img style="aspect-ratio:645/148;" src="https://news.stocktwits-cdn.com/X_retail_sentiment_jpg_fefc3e4bf2.webp" alt="X retail sentiment.jpg" width="645" height="148"><figcaption>X sentiment and message volume March 27, 2025, as of 9:30 pm ET | Source: Stocktwits</figcaption></figure>One user quipped it’s “time to ride.”<stembedurl>https://stocktwits.com/ucla44life/message/609477986</stembedurl>Another recommends investors use the “buy on dips” strategy to accumulate U.S. Steel shares.<stembedurl>https://stocktwits.com/ucla44life/message/609454751</stembedurl>Data from Koyfin shows the average price target for U.S. Steel is $41.44, which is lower than the stock’s closing price on Thursday.Of the 10 brokerage calls, six either have a ‘Buy’ or a ‘Strong Buy’ recommendation, while four have a ‘Hold’ rating.<a href="https://stocktwits.com/symbol/XTIA">US Steel’s stock</a> has gained over 26% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/xtia-stock-nosedives-on-proposed-public-offering/chJduWJRbEg">XTIA Stock Nosedives On Proposed Public Offering, Retail Turns Bearish</a>

Nippon Steel And US Steel Take Legal Actions Against U.S. Government

US Steel Stock Surges After-Hours As Nippon Reportedly Mulls Boosting Investment Offer: Retail Stays Ultra-Bullish

Nippon will use the funds to rebuild US Steel’s aging manufacturing facilities.

Nippon, US Steel merger talks persist, Trump approval sought- Semafor

Investing.com-- Nippon Steel Corp (TYO:5401) and U.S. Steel (NYSE:X) have remained in active talks to preserve their $14 billion merger agreement and are also negotiating with the Donald Trump administration, Semafor reported on Thursday. 

NIPPON STEEL CORP. engages in the manufacture and trade of steel products. It operates through the following segments: Steel Manufacturing, Engineering, Chemicals & Materials and System Solutions. The Steel Manufacturing segment produces and distributes steel sheets, plates, bars and wire rods, pipes and tubes, and machinery parts. The Engineering segment develops steel plants, heat management facilities, and industrial machinery and equipment. The Chemicals & Materials segment produces and trades chemical products, carbon materials, epoxy resins, semiconductors, stainless-steel foils, silicon carbide wafers, carbon fibers, and metal substrates for catalytic converters. The System Solutions segment includes information technology infrastructure services. The company was founded on April 1, 1950 and is headquartered in Tokyo, Japan.

Nippon Steel Corporation - ADR

Fred Wilson - Union Square Ventures

Abigail Johnson - Fidelity

Jim Cramer - Media Personality

Josh Brown - Ritholtz Wealth Management

A lifetime achievement for industry titans. This honor is reserved for an individual whose groundbreaking contributions have shaped the investing landscape and how we engage with the markets.

Current Price	$3.60
Prev Close	$3.65
Open	$3.72
Dividend Yield	3.40%
50-Day Moving Average	$4.09
Beta	0.55
Avg. Volume	182,637.26
PE Ratio	-43.85

52-Week High	$4.79
52-Week Low	$3.55
Market Capitalization	$18.81B
EPS (Annual)	$0.4604
Price to Book	0.55
Revenue Per Employee	$501,018.11

NPSCY
Nippon Steel Corporation - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NPSCY News

NPSCYNippon Steel Corporation - ADR